Carbidopa And Levodopa Tablet
Product Images NDC 63629-4134

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Carbidopa And Levodopa (NDC 63629-4134). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure 1 (Carbilevo Str1)

Chemical structure of Carbidopa, displayed with its molecular components including a benzene ring, hydroxyl groups, and hydrazine moiety, alongside a water molecule (H2O). This image represents the active ingredient Carbidopa in the combination product Carbidopa and Levodopa.*

FDA Label Image

Chemical Structure 2 (Carbilevo Str2)

Chemical structure of Carbidopa and Levodopa, showing a benzene ring with hydroxyl groups, an amino group, and a carboxylic acid functional group attached via a side chain.*

FDA Label Image

Label (Lbl636294134)

Label for Carbidopa and Levodopa Tablets USP, 25 mg/250 mg, oral tablets. The label indicates the package contains 30 tablets and lists Bryant Ranch Prepack as the repackager and Aurobindo Pharma Limited as the manufacturer. Storage instructions and dosage QR code are also visible along with the NDC 63629-4134-1 and barcodes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.